|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The CVC removal distress syndrome: an unappreciated complication of central venous catheter removal显示文摘 | Kim DK Gottesrnan MH Forero A | 1998 | Am Surg1998，64，4： | 1 |
| 2 | Asthma,health behaviors,social adjustment,and psychosomatic symptomsin adolenacence显示文摘 | Forero R Bauman A Young L | 1996 | J Asthma1996，33，： | 1 |
| 3 | History of antibody therapy for non-Hodgkins lymphoma显示文摘 | Forero A Lobuglio AF | 2003 | Semin Oncol2003，30，6117： | 1 |
| 4 | Multicenter phaseⅡstudy of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006显示文摘 | Rimawi MF Mayer IA Forero A | 2013 | J Clin Oncol2013，31，14： | 1 |
| 5 | Crossed nanotube junctions 显示文摘 | FUHRER M S NYGARD J SHIH L FORERO M YOON Young-gui MAZZONI M S C CHOI H J IHM J LOUIE S G Z A MCEUEN P L | 2000 | Science2000，288，： | 1 |
| 6 | Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma显示文摘 | Forero A Weiden P L Vose J M | 2004 | Blood2004，104，1： | 1 |
| 7 | Advances in the management of early esophageal carcinoma显示文摘 | Arantes V Forero Pi~eros E A Yoshimura K | 2012 | Rev Col Bras Cir2012，39，6： | 1 |
| 8 | Neuropsychiatric genetics in developing countries: Current challenges显示文摘Neuropsychiatric disorders(NPDs) constitute a heavyburden on public health systems around the world and studies have demonstrated that the negative impact of NPDs is larger in Low and Middle Income Countries(LMICs). In recent decades, several studies have come to the understanding that genetic factors play a major role in the risk for a large number of NPDs. However, few neuropsychiatric genetics studies have been published from LMICs. In this Editorial, we discuss important issues impinging on advances in neuropsychiatric genetics research in LMICs. It is essential that scientists educate policymakers and officials of funding agencies on the importance of providing adequate funding for research in these areas. Development of local well-supported research programs focused on NPD genetics should be an important asset to develop; it would facilitate the establishment of sustainable research efforts that could lead to appropriate diagnosis and specific, affordable and feasible interventions in LMICs. It is important to point out that research into the biological basis of human NPDs is not only an academic effort reserved for a few elite institutions in economically developed countries, but it is vitally important for the mental health of people around the world. | Diego A Forero Alberto Vélez-van-Meerbeke Smita N Deshpande Humberto Nicolini George Perry | 2014 | World Journal of Psychiatry2014，4，4： | 1 |
| 9 | Initial phaseⅡ results of SGN-30 (anti-CD-30 monoclonal antibody) in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL) 显示文摘 | Forero A Bemsein S Gopal A | 2005 | J Clin Oncol2005，23，： | 1 |
| 10 | Cytotoxic and Antiviral Activities of Colombian Medicinal Plant Extracts of the Euphorbia genus 显示文摘 | Betancur- Galvis L A Morales G E Forero J E | 2002 | Mem Inst Oswaldo Cruz Rio de Janeiro2002，4，97： | 1 |
| 11 | Phase I , pharmacokinetic, and DCE-MRI correlative study of AVE8062A, an antivascular combretastatin analogue, administered weekly for 3 weeks every 28 days 显示文摘 | TOLCHER A W FORERO L CELIO P | 2003 | Proc Am Soc Clin Oncol2003，22，9： | 1 |
| 12 | Phase Ⅰ , pharmacok-inetic and biologic study of OSI-774, a selective epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor in combination with paclitaxel and carboplatin显示文摘 | Patnaik A Hammond LA | 2002 | Proc ASCO2002，21，25： | 1 |
| 13 | History of antibody therapy for non-Hodgkin's lymphoma显示文摘 | Forero A Lobuglto AF | 2003 | Semim Oncol2003，30，17： | 1 |
| 14 | Phase Ⅰ,pharmacoki netic (PK) and biologic study of OSI-774, a selective epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor in combination with paclitaxel and carboplatin显示文摘 | Forero L Patnaik A Hammond LA | 2002 | Proc Am SocClin Oncol2002，21，： | 1 |
| 15 | Phase I trial of anovel anti-CD20 fusion protein in pretargeted radioin-nmmothempy for B-cell non-Hodgkin lymphema显示文摘 | Forero A Weiden PL Vose JM | 2004 | Blood2004，104，1： | 1 |
| 16 | A method to estimate the Patel-Teja equation of state constants显示文摘 | Forero Luis A Vel(a)squez Jorge A | | 0，，11： | 1 |
| 17 | Pilot study of dacetuzumab in combination with rituximab and gemcit- abine for relapsed or refractory diffuse large B - cell lymphoma 显示文摘 | FORERO - TORRES A BARTLETT N BEAVEN A | 2013 | Leuk Lymphoma2013，54，2： | 1 |
| 18 | Factor analysis with ordinal indicators:A Monte Carlo study comparing DWLS and ULS estimation显示文摘 | Forero C.G Maydeu-Olivares A Gallardo-Pujol D | | 0，，04： | 1 |
| 19 | Synaptic dys-function and oxidative stress in Alzheimer's disease:emergingmechanisms显示文摘 | FORERO D A CASADESUS G PERRY G | 2006 | J Cell Mol Med2006，10，3： | 1 |
| 20 | History of antibody therapy for non Hodgkin ' s lymphoma 显示文摘 | Forero A Lobuglio AF | 2003 | Semin Oneol2003，30，617： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员